Bioinformatics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product & Services (Bioinformatics Tools, Bioinformatic Platforms and Bioinformatic Services), By Type (Genomics & Proteomics, Simulation Studies & Molecular Modelling, Genetic Engineering, Others), By Application (Metagenomics, Drug Discovery, Precision Medicine, Others), By End User (In
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationBioinformatics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product & Services (Bioinformatics Tools, Bioinformatic Platforms and Bioinformatic Services), By Type (Genomics & Proteomics, Simulation Studies & Molecular Modelling, Genetic Engineering, Others), By Application (Metagenomics, Drug Discovery, Precision Medicine, Others), By End User (In
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 10.58 Billion |
| CAGR (2023-2028) | 12.2% |
| Fastest Growing Segment | Genomics & Proteomics |
| Largest Market | North America |
Market Overview
Key Market Drivers
Increasing Demand for Nucleic Acid and Protein Sequencing
Increasing Initiatives from Governments and Private Organizations
Accelerating Growth of Proteomics and Genomics
Increasing Research on Molecular Biology and Drug Discovery
Key Market Challenges
Lack of Well-defined Standards and Common Data Formats for Integration of Data
Data Complexity Concerns and Lack of User-friendly Tools
Key Market Trends
Artificial Intelligence (AI) and Machine Learning
Increasing Applications in Clinical Bioinformatics
Segmental Insights
Product & Services Insights
Based on the analysis of Product & Services, the market is segmented into three categoriesBioinformatics Tools, Bioinformatic Platforms, and Bioinformatic Services. The bioinformatics platforms sector has been the primary source of revenue and is projected to continue this trend in the foreseeable future. This can be attributed to the increasing applications of platforms and the growing demand for advanced tools in drug development. The surge in platform applications is driven by the life science industry's need for efficient identification and modification of structures, which in turn facilitates the drug design process and assessment of therapeutic effects. Additionally, the emphasis on efficiency and safety in drug development has led to a greater demand for improved tools. Consequently, these factors are expected to drive the growth of the Bioinformatics Market in the upcoming period.
Application Insights
The Metagenomics segment dominated the Bioinformatics Market in 2022, driven by its application and is projected to exhibit substantial growth throughout the forecast period. Bioinformatics assumes a crucial role in the study of genetic variations, identification of disease-related biomarkers, and facilitation of personalized medicine approaches. This segment's growth can be attributed to the widespread utilization of bioinformatics tools and algorithms for analyzing and interpreting genomic data. Furthermore, the extensive adoption of Next-Generation Sequencing (NGS) technologies, which generate vast amounts of genomic data, has further fueled this growth. The recent introduction of instruments capable of producing millions of DNA sequence reads in a single run has revolutionized the field of genetics. These advancements have provided cost-effective, genome-wide sequence readouts, enabling applications ranging from chromatin immunoprecipitation and mutation mapping to polymorphism discovery and noncoding RNA exploration. The growth of the genomics segment in the Bioinformatics Market is driven by advancements in DNA sequencing technology during the forecast period.
Regional Insights
Recent Developments
- In June 2022, LatchBio, a biotechnologyresearch startup based in California, introduced an end-to-end bioinformaticsplatform. This platform aims to facilitate the handling of vast biotech data,ultimately expediting scientific discovery.
- In March 2022, ARUP unveiled Rio, abioinformatics pipeline and analytics platform. This innovative solution aimsto enhance the speed and accuracy of next-generation sequencing test results.
- In January 2020, Charles River Laboratories,Inc. forged a partnership with Fios Genomics. Through this collaboration,Charles River Laboratories gains access to Fios Genomics' expertise in thefields of bioinformatics, statistics, and biology.
Key Market Players
- 3rd Millennium Inc.
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- BioWisdom Ltd
- Quest Diagnostics (CeleraCorporation)
- Dassault Systèmes SE
- Illumina, Inc.
- Geneva Bioinformatics SA
- Perkin Elmer, Inc.
- Lineage Cell Therapeutics(BioTime Inc.)
| By Product & Services | By Type | By Application | By End User | By Region |
|
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy